Blog

Our Research and Training Institute (RTI) has a new Executive Director, Kevin Stein, PhD. Read on below for a Q&A with Kevin (KS) and Operations Manager Levi James (LJ) to get to know the newest member of the RTI Team and his background in cancer research. 

For a special “Flashback Friday”, today we want to remind you of a useful resource that was launched at the beginning of the year in collaboration with our friends at Janssen Pharmaceuticals, along with two other leading patient advocacy organizations: the American Cancer Society and CancerCare.

Recently the Centers for Medicare and Medicaid Services (CMS) released new guidance for the Affordable Care Act’s section 1332 waivers, expanding the power of 1332s and allowing states to use the waivers to adjust traditional compliance with ACA requirements.

On Thursday, October 25, we officially welcomed Gilda’s Club Memphis into the Cancer Support Community’s international network of hope and support for all people affected by cancer.

Each month, the Cancer Policy Insitute profiles advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our featured advocate for the month of October and her passion to advocate for and destigmatize lung cancer. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!

President Trump recently signed two bills into law aimed at reducing patients’ out-of-pocket spending on prescription medications. The “Patient’s Right to Know Drug Prices Act” and the “Know the Lowest Price Act” address a practice known as “gag clauses.”

Like many women in communities of color, Asian-Americans face disproportionate health outcomes. Many Asian-American women lack important education about breast cancer symptoms, which can lead to later diagnoses and worse health outcomes.

While government officials and the medical community celebrate advances in precision medicine, patients often struggle to navigate a treatment landscape that increasingly resembles science fiction.

As the Midterm Election approaches and many prepare for the holiday season, it’s critical to remember that the open enrollment period to purchase health insurance coverage for 2019 is quickly approaching as well. This is the time to make sure that you and your loved ones have access to comprehensive, quality, and affordable coverage through the Health Insurance Marketplace.

While clear advances have certainly been made in treatment and survival, there remains a critical need to better understand the quality of life implications of survivorship. We applaud the multidisciplinary approach of cancer care, and also advocate strongly for an even more comprehensive view of treating patients, above and beyond the treatment of their disease.